HealthCare Global Enterprises (NSE:HCG) Beta: 0.3273 (As of Jun. 25, 2026)


NSE:HCG HealthCare Global Enterprises Ltd NSE:HCG
79 GF Score
Price ₹614.20
GF Value ₹575.94
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is HealthCare Global Enterprises Beta?

HealthCare Global Enterprises NSE:HCG +1.50% 79 Beta is 0.3273 as of Jun. 25, 2026. GuruFocus rates NSE:HCG with a GF Score™ of 79/100 and a GF Value™ of ₹575.94 (Fairly Valued). The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), HealthCare Global Enterprises's Beta is 0.3273.


HealthCare Global Enterprises  (NSE:HCG) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


HealthCare Global Enterprises Beta Related Terms


HealthCare Global Enterprises Beta Historical Data

* Premium members only.

The historical data trend for HealthCare Global Enterprises's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthCare Global Enterprises Beta Chart

HealthCare Global Enterprises Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.96 0.15 -0.05 -0.00 0.39

HealthCare Global Enterprises Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.04 -0.06 0.07 0.39

NSE:HCG vs HCA, THC, DVA: Beta Comparison

For the Medical Care Facilities subindustry, HealthCare Global Enterprises's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthCare Global Enterprises Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's Beta distribution charts can be found below:

* The bar in red indicates where HealthCare Global Enterprises's Beta falls into.


NSE:HCG
79GF Score
HealthCare Global Enterprises Ltd NSE:HCG
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthCare Global Enterprises Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.3273 mean?
HealthCare Global Enterprises (NSE:HCG) has a Beta of 0.3273 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for HealthCare Global Enterprises and its competitors.
Is HealthCare Global Enterprises' Beta too high?
HealthCare Global Enterprises' current Beta is 0.3273. Overall, HealthCare Global Enterprises has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' Beta compare to HCA and THC?
HealthCare Global Enterprises' Beta of 0.3273 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for HealthCare Global Enterprises and its competitors. HealthCare Global Enterprises's current Beta is 0.3273. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Fairly Valued. The stock's GF Value™ is ₹575.94, compared to a current price of ₹614.20 — trading 6.6% above its estimated fair value. The current Beta is 0.3273. HealthCare Global Enterprises' overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current Beta is 0.3273 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?

Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued. The current stock price of ₹614.20 is trading 6.6% above its estimated GF Value™ of ₹575.94. GuruFocus considers HealthCare Global Enterprises to be Fairly Valued.

Key valuation signals for NSE:HCG:

  • Beta: 0.3273
  • GF Value™: ₹575.94 vs. price of ₹614.20 (6.6% above fair value)
  • GF Score™: 79/100 with 2 warning signs

No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HealthCare Global Enterprises Business Description

Other Exchanges 539787:India
Address Mission Road, No. 3, Ground Floor, Tower Block, Unity Building Complex, Bengaluru, KA, IND, 560027
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
79GF Score

Get the complete analysis for NSE:HCG

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹614.20
Price
₹575.94
GF Value